Pharmacy Clinical Prior Authorization Assistance Chart Effective February 2018

Size: px
Start display at page:

Download "Pharmacy Clinical Prior Authorization Assistance Chart Effective February 2018"

Transcription

1 About Pharmacy Clinical Prior Authorizations Clinical prior authorizations (PA) are based on evidence-based clinical criteria and nationally recognized peer-reviewed information. The PA may apply to an individual drug or a drug class on the formulary, including some preferred and non-preferred drugs. Clinical PAs approved by the Texas Drug Utilization Review Board are available for use by the Vendor Drug Program (VDP) for traditional Medicaid (or fee-for-service, FFS) and by managed care organizations (MCO). There are certain clinical PAs that all MCOs are required to perform. Usage of all other clinical PA will vary between MCO at the discretion of each MCO. FFS: txvendordrug.com/formulary/prior-authorization/ffs-clinical-pa MCO: txvendordrug.com/formulary/prior-authorization/mco-clinical-pa Obtaining Prior Authorization for Medicaid Managed Care Prescribing providers or their representatives must contact the MCO. Call center phone numbers vary by MCO, and the Prescriber MCO Assistance Chart identifies prior authorization and member call center phone numbers for each MCO. txvendordrug.com/sites/txvendordrug/files/docs/managed-care/prescriber-assistancechart.pdf About the CPA Assistance Chart Each prior authorization guide includes a description of how the prior authorization requests are evaluated. All these steps apply to FFS Medicaid claims processed by VDP. This assistance chart identifies which prior authorizations are utilized by each MCO and how those prior authorizations relate to those used by VDP. VDP AET AGP BCS CMC HLT CFT CHC CKC DEL DRC EPF FCR MHT PRK SCW SND SUP TXC UHC Abbreviations Vendor Drug Program / FFS Aetna Amerigroup Blue Cross Blue Shield Children's Medical Center Cigna HealthSpring Community First Community Health Choice Cook Children's Dell Children's Health Plan Driscoll Children's El Paso First Premier FirstCare Molina Healthcare of Texas Parkland Scott & White Sendero Superior HealthPlan Texas Children's United Healthcare Symbol Definition Follows all steps of the prior authorization Does not follows all steps of the prior authorization Prior authorization does not apply Rev. 02/2018 mco-pcpaac TxVendorDrug.com PAGE 1 OF 7

2 February 2018 Revisions Added Dupixent Added Diclofenac Gel & Topical Solution Removed methylnatrexone bromide (Relistor) due to combination with other GI motility agents Brand Names Included Within Categories Prior Authorization Aliskiren Agents Cystic Fibrosis Cytokine and CAM Agonists Gaucher s Disease Gastrointestinal (GI) Motility Fentanyl Agents Hereditary Angioedema Injectable Pulmonary Hypertension Agents Leukotreine Modifiers Topical Immunomodulators Drugs Tekamlo, Tekturna, Tekturna HCT Kalydeco, Orkambi* Actemra, Cimzia, Ilaris, Kineret, Orencia, Simponi, Stelara, Xeljanz Cerezyme, Elelyso, Vpriv, Zavesca Amitiza, Linzess, Lotronex, Movantik, Relistor Abstral, Lazanda, Subsys, Actiq, Duragesic, Fentora Cinryze, Firazyr Flolan, Remodulin, Veletri Singulair (montelukast), Acccolate (zafirlukast), Zyflo (zileuton) Elidel, Protopic, Eucrisa Rev. 02/2018 mco-pcpaac TxVendorDrug.com PAGE 2 OF 7

3 Prior Authorization Information ADDADHD Medications Alinia (Nitazoxanide) Aliskiren-Containing Agents Allergen Extracts - Grastek/Oralair/Ragwitek Altabax (Retapamulin) Androgenic agents Antiemetics Antipsychotics* Anxiolytics and Sedatives/Hypnotics Byetta (Exenatide Injection) Carisoprodol Colcrys Contraceptives for CHIP clients Copaxone (Glatiramer) Cough/Cold Medications COX-2 Inhibitors Cymbalta Cystic Fibrosis (incl. Orkambi*) Cytokine and CAM Antagonists Rev. 02/2018 mco-pcpaac TxVendorDrug.com PAGE 3 OF 7

4 Desmopressin Dextromethorphan Overutilization Diabetic Test Strips Diclofenac Gel & Topical Solution Drug Regimen Optimization Dupixent Duplicate Therapy Emflaza Enzymes Erythropoiesis- Stimulating Agents Flexeril/Amrix (Cyclobenzaprine) Fentanyl Agents Forteo (Teriparatide) Fosrenol (Lanthanum) Gaucher s Disease Agents GI Motility Agents Growth Hormones H.P. Acthar Hepatitis C Virus (Initial)* Hepatitis C Virus (Refill)* Hereditary Angioedema Agents Rev. 02/2018 mco-pcpaac TxVendorDrug.com PAGE 4 OF 7

5 Imiquimod (Aldara/Zyclara) Increlex (Mecasermin) Inj. Pulmonary Hypertension Agents Ketorolac (Toradol) Leukotriene Modifiers Lidocaine Patches Lovaza Capsules Lyrica Makena Nuedexta Neurontin (Gabapentin) Nuplazid Opiate Overutilization Opiate/Benzo/Muscle Relaxant Combinations OxyContin (Oxycodone) PCSK9 Inhibitors Phenergan/Phenergan Containing Products* Plavix Propylthiouracil Provigil (Modafinil) Ranexa Revatio (Sildenafil) Rev. 02/2018 mco-pcpaac TxVendorDrug.com PAGE 5 OF 7

6 Savella Sitagliptin (Januvia) Suboxone/Subutex Symlin (Pramlintide Acetate) Synagis (Palivizumab) Thiazolidinediones Topical Acne Agents (Non Retinoid) Topical Immunomodulators Tyvaso Starter Kit (CHIP) Victoza (Liraglutide) Solution for Injection Xenical (Orlistat) Xenazine Xifaxan (Rifaximin) Xyrem Zelboraf Rev. 02/2018 mco-pcpaac TxVendorDrug.com PAGE 6 OF 7

7 Some MCOs have a preferred brand of glucose monitoring test strips as shown below. If no brand is listed, the prescriber may choose any brand on VDP formulary. MCO AET AGP BCS CMC HLT CFT CHC CKC DEL DRC EPF FCR MHT PRK SCW SND SUP TXC UHC Preferred Product Name OneTouch TRUETEST and TRUE METRIX TEST STRIPS - Nipro Freestyle, Truetuest, Precision Xtra, Truetrack Nipro and Abbott (Freestyle and Precision). TRUE METRIX - Nipro OneTouch Rev. 02/2018 mco-pcpaac TxVendorDrug.com PAGE 7 OF 7

PRESCRIPTION DRUGS REQUIRING PRIOR AUTHORIZATION

PRESCRIPTION DRUGS REQUIRING PRIOR AUTHORIZATION Abstral fentanyl citrate oral tablet Controlled Dangerous substance Actemra tocilizumab Monoclonal antibody Acthar corticotropin Hormone Actimmune interferon gamma 1b Interferon Actiq fentanyl citrate

More information

PRESCRIPTION DRUGS REQUIRING PRIOR AUTHORIZATION

PRESCRIPTION DRUGS REQUIRING PRIOR AUTHORIZATION Abstral fentanyl citrate oral tablet Controlled Dangerous substance Actemra tocilizumab Monoclonal antibody Acthar corticotropin Hormone Actimmune interferon gamma 1b Interferon Actiq fentanyl citrate

More information

Texas Vendor Drug Program. Formulary Drug Index File Layout. Layout effective: Jul. 2, 2018 Document update: Oct. 1, 2018

Texas Vendor Drug Program. Formulary Drug Index File Layout. Layout effective: Jul. 2, 2018 Document update: Oct. 1, 2018 Texas Vendor Drug Program Formulary Drug Index File Layout Layout effective: Jul. 2, 2018 Document update: Oct. 1, 2018 The Vendor Drug Program provides a weekly update of resource data available for download

More information

Texas Vendor Drug Program. Formulary Delimited File Layout. April 26, 2017

Texas Vendor Drug Program. Formulary Delimited File Layout. April 26, 2017 Texas Vendor Drug Program Formulary Delimited File Layout April 26, 2017 The Vendor Drug Program provides a weekly update of resource data available for download from txvendordrug.com/resources/downloads.

More information

Fentanyl Agents Clinical Edit Criteria

Fentanyl Agents Clinical Edit Criteria Fentanyl Agents Clinical Edit Criteria Drug/Drug Class: Fentanyl Agents Superior HealthPlan follows the guidance of the Texas Vendor Drug Program (VDP) for all clinical edit criteria. Superior has adjusted

More information

ANTIDEPRESSANTS. Details. Step Therapy 2018 Last Updated: 8/21/2018

ANTIDEPRESSANTS. Details. Step Therapy 2018 Last Updated: 8/21/2018 ANTIDEPRESSANTS EMSAM PATCH 24 HOUR 12 MG/24HR TRANSDERMAL EMSAM PATCH 24 HOUR 6 MG/24HR TRANSDERMAL EMSAM PATCH 24 HOUR 9 MG/24HR TRANSDERMAL FETZIMA CAPSULE EXTENDED RELEASE 24 HOUR 120 MG ORAL FETZIMA

More information

METABOLIC, IMMUNE DISORDERS OR INHERITED RARE DISEASE ALPHA-1 PROTEINASE INHIBITORS ARANESP BLOOD CELL DEFICIENCY ARANESP ARCALYST

METABOLIC, IMMUNE DISORDERS OR INHERITED RARE DISEASE ALPHA-1 PROTEINASE INHIBITORS ARANESP BLOOD CELL DEFICIENCY ARANESP ARCALYST PRIOR AUTHORIZATION LIST (SUBJECT TO CHANGE) MEDICATION THERAPEUTIC CATEGORY MODULE ACTEMRA INFLAMMATORY CONDITIONS ACTEMRA ADCIRCA PULMONARY HYPERTENSION PDE-5 INHIBITORS FOR PAH ADDYI SEXUAL DISORDERS

More information

TRICARE Uniform Formulary. Pre-Authorization Requirements

TRICARE Uniform Formulary. Pre-Authorization Requirements TRICARE Uniform Formulary Pre-Authorization Requirements The Department of Defense (DoD) requires pre-authorization on select medications. These medications are on the DoD s pre-authorization list because

More information

RAHF PFM ALPHANINE SD COAGULATION FACTOR IX J7193 COAGULATION FACTOR IX (RFIXFC)

RAHF PFM ALPHANINE SD COAGULATION FACTOR IX J7193 COAGULATION FACTOR IX (RFIXFC) INFECTIOUS DISEASE ACTIMMUNE INTERFERON GAMMA 1B J9216 ADVATE RAHF PFM ONCOLOGY ORAL AFINITOR EVEROLIMUS J7527 INFECTIOUS DISEASE ALFERON N INTERFERON ALFA N3 J9215 ALPHANATE VWF J7186 ALPHANINE SD J7193

More information

Exclusion Reasons Presumption of Long- Term Non-Acute Administration C9399 Unclassified Drugs or

Exclusion Reasons Presumption of Long- Term Non-Acute Administration C9399 Unclassified Drugs or Noridian Healthcare Solutions, LLC Jurisdiction F Part B Self-Administered Drug (SAD) Exclusion List (A53033); Effective 8/7/2017 The following medications are considered self-administered and are not

More information

ANTIDEPRESSANTS. Details. Step Therapy 2017 Last Updated: 5/23/2017

ANTIDEPRESSANTS. Details. Step Therapy 2017 Last Updated: 5/23/2017 ANTIDEPRESSANTS EMSAM PATCH 24 HOUR 12 MG/24HR TRANSDERMAL EMSAM PATCH 24 HOUR 6 MG/24HR TRANSDERMAL EMSAM PATCH 24 HOUR 9 MG/24HR TRANSDERMAL FETZIMA CAPSULE EXTENDED RELEASE 24 HOUR 120 MG FETZIMA CAPSULE

More information

PHARMACY AND THERAPEUTICS COMMITTEE 4 th Quarter 2017

PHARMACY AND THERAPEUTICS COMMITTEE 4 th Quarter 2017 PHARMACY AND THERAPEUTICS COMMITTEE 4 th Quarter 2017 A meeting of the Health Partners Pharmacy and Therapeutics (P&T) Committee was held on September and December 2017. The following are the recommendations

More information

Step Therapy Approval Criteria

Step Therapy Approval Criteria Effective Date: 01/01/2019 This document contains for the following medications: 1. Colcrys (colchicine) 2. Dovonex (calcipotriene) 3. Enbrel (etanercept) 4. Humira (adalimumab) 5. Imitrex Injection vial

More information

Duragesic patch. Duragesic patch (fentanyl patch) Description

Duragesic patch. Duragesic patch (fentanyl patch) Description 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.70.31 Subject: Duragesic patch Page: 1 of 6 Last Review Date: March 18, 2016 Duragesic patch Description Duragesic patch (fentanyl

More information

Michigan Department of Community Health Quantity Limitations

Michigan Department of Community Health Quantity Limitations Abstral (fentanyl) sl tab all strength Acetaminophen Actonel Actonel 35mg Adderall XR 5mg, 10mg, 15mg 240 per 34 days 3 gm/day 2 every 28 days 4 every 28 days Advair Diskus. No more than 180 every 30 days

More information

Oregon Health Plan prescription benefit updates

Oregon Health Plan prescription benefit updates Oregon Health Plan prescription benefit updates EOCCO s prescription program is a pharmacy benefit that offers members a choice of safe and effective medication treatments. The program also helps you save

More information

2018 BCN Advantage Prior Authorization Criteria Last updated: November, 2017

2018 BCN Advantage Prior Authorization Criteria Last updated: November, 2017 Abstral Actemra Adcirca Adempas Afinitor Afinitor- Disperz Alecensa Alunbrig Amitiza Amitriptyline Ampyra Anadrol-50 Androgel Androderm Aralast NP Aranesp Arcalyst Armodafinil Aubagio Avonex Bavencio Beleodaq

More information

2018 BCN Advantage Prior Authorization Criteria Last updated: April, 2018

2018 BCN Advantage Prior Authorization Criteria Last updated: April, 2018 Abstral Actemra Adcirca Adempas Aliqopa Afinitor Afinitor- Disperz Alecensa Alunbrig Amitiza Amitriptyline Ampyra Anadrol-50 Androgel Androderm Aralast NP Aranesp Arcalyst Armodafinil Aubagio Avonex Bavencio

More information

Movantik (naloxegol), Relistor (methylnaltrexone bromide), Symproic (naldemedine)

Movantik (naloxegol), Relistor (methylnaltrexone bromide), Symproic (naldemedine) Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.50.06 Subject: Opioid Antagonist Drug Class Page: 1 of 7 Last Review Date: November 30, 2018 Opioid Antagonist

More information

Step Therapy Criteria

Step Therapy Criteria ADCIRCA ADCIRCA Coverage will be provided if the member has filled a prescription for sildenafil (at least a 30 day supply within the past 365 ) ELIDEL 76-F ELIDEL Coverage will be provided if the member

More information

Texas Association of Rural Health Clinics Annual Education Conference

Texas Association of Rural Health Clinics Annual Education Conference Supported by TORCH Texas Organization of Rural & Community Hospitals Texas Association of Rural Health Clinics Annual Education Conference Agenda & Registration Information July 30-August 1, 2014 Omni

More information

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice Provider Bulletin June 24, 2016 Summary of change The Pharmacy and Therapeutics Committee reviewed and approved the formulary changes listed in the table below on March 29, 2016. What this means to you

More information

ADHD STIMULANTS - SCORE

ADHD STIMULANTS - SCORE ADHD STIMULANTS - SCORE Step Therapy Strattera Patient needs to have a paid claim for two generic formulary ADHD stimulant medications. Formulary ID# 00017034 Last Updated: 08/01/2017 1 ALPHA GLUCOSIDASE

More information

STAT Bulletin. Drug Therapy Guideline Updates. To: All Primary Care Physicians and Specialists Contracts Affected: All Lines of Business

STAT Bulletin. Drug Therapy Guideline Updates. To: All Primary Care Physicians and Specialists Contracts Affected: All Lines of Business STAT Bulletin November 28, 2011 Volume 9: Issue 27 To: All Primary Care Physicians and Specialists Contracts Affected: All Lines of Business Drug Therapy Guideline Updates Why you re receiving this Stat

More information

IHCP bulletin INDIANA HEALTH COVERAGE PROGRAMS BT MAY 29, 2012

IHCP bulletin INDIANA HEALTH COVERAGE PROGRAMS BT MAY 29, 2012 IHCP bulletin INDIANA HEALTH COVERAGE PROGRAMS BT201218 MAY 29, 2012 Changes to the Preferred Drug List Changes to the Preferred Drug List (PDL) were made at the May 18, 2012, Drug Utilization Review (DUR)

More information

Prescription Drug Benefit Rider V

Prescription Drug Benefit Rider V Prescription Drug Benefit Rider V Your Certificate of Coverage is amended as described in this document. This Rider becomes a part of your Certificate of Coverage and is subject to all provisions of your

More information

Step Therapy Approval Criteria

Step Therapy Approval Criteria Effective Date: 01/01/2018 This document contains Step Therapy Approval Criteria for the following medications: 1. Colcrys (colchicine) 2. Dovonex (calcipotriene) 3. Enbrel (etanercept) 4. Humira (adalimumab)

More information

Secretary for Health and Family Services Selections for Preferred Products

Secretary for Health and Family Services Selections for Preferred Products Secretary for Health and Family Services Selections for Preferred Products This is a summary of the final Preferred Drug List (PDL) selections made by the Secretary for Health and Family Services based

More information

ADHD STIMULANTS - SCORE

ADHD STIMULANTS - SCORE Step Therapy Trillium 5 Tier Effective Date: 12/01/2017 Approval Date: 10/24/2017 ADHD STIMULANTS - SCORE Strattera Trial of two generic formulary products from the following: atomoxetine or ADHD stimulant

More information

STAT Bulletin. Drug Therapy Guideline Updates. To: All Primary Care Physicians and Specialists Contracts Affected: All Lines of Business

STAT Bulletin. Drug Therapy Guideline Updates. To: All Primary Care Physicians and Specialists Contracts Affected: All Lines of Business STAT Bulletin November 28, 2011 Volume 17: Issue 34 To: All Primary Care Physicians and Specialists Contracts Affected: All Lines of Business Drug Therapy Guideline Updates Why you re receiving this Stat

More information

Embeda. Embeda (morphine sulfate and naltrexone hydrochloride) Description

Embeda. Embeda (morphine sulfate and naltrexone hydrochloride) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.70.39 Subject: Embeda Page: 1 of 6 Last Review Date: March 18, 2016 Embeda Description Embeda (morphine

More information

ALBUTEROL - SCORE. Products Affected. Details. Step Therapy Criteria Golden State Medicare Health Plan, Golden (HMO) Last Updated: 09/01/2018

ALBUTEROL - SCORE. Products Affected. Details. Step Therapy Criteria Golden State Medicare Health Plan, Golden (HMO) Last Updated: 09/01/2018 Step Therapy Golden State Medicare Health Plan, Golden (HMO) Last Updated: 09/01/2018 ALBUTEROL - SCORE Ventolin Hfa Trial of ProAir 1 ANTIDEPRESSANTS - SCORE Aplenzin Desvenlafaxine Er TB24 100MG, 50MG

More information

CYTOKINE AND CAM ANTAGONIST UTILIZATION IN MISSISSIPPI MEDICAID

CYTOKINE AND CAM ANTAGONIST UTILIZATION IN MISSISSIPPI MEDICAID CYTOKINE AND CAM ANTAGONIST UTILIZATION IN MISSISSIPPI MEDICAID BACKGROUND Cytokine and cell-adhesion molecule (CAM) antagonists have a major role in the treatment of chronic inflammatory diseases such

More information

BRINTELLIX. Step Therapy Criteria HealthTeam Advantage Formulary ID: Version 6 Effective Date: 1/1/2016. PRODUCT(s) AFFECTED BRINTELLIX

BRINTELLIX. Step Therapy Criteria HealthTeam Advantage Formulary ID: Version 6 Effective Date: 1/1/2016. PRODUCT(s) AFFECTED BRINTELLIX BRINTELLIX BRINTELLIX Claim will pay automatically for brintellix if enrollee has a paid claim for at least a 1 days supply of any 2 generic formulary antidepressants in the past 365 days. Otherwise, brintellix

More information

ARISTADA. Products Affected Step 2: ARISTADA PREFILLED SYRINGE 1064 MG/3.9ML INTRAMUSCULAR ARISTADA PREFILLED SYRINGE 441 MG/1.

ARISTADA. Products Affected Step 2: ARISTADA PREFILLED SYRINGE 1064 MG/3.9ML INTRAMUSCULAR ARISTADA PREFILLED SYRINGE 441 MG/1. ARISTADA ARISTADA PREFILLED SYRINGE 1064 MG/3.9ML INTRAMUSCULAR ARISTADA PREFILLED SYRINGE 441 MG/1.6ML INTRAMUSCULAR ARISTADA PREFILLED SYRINGE 662 MG/2.4ML INTRAMUSCULAR ARISTADA PREFILLED SYRINGE 882

More information

Aetna Better Health. Specialty Drug Program

Aetna Better Health. Specialty Drug Program Aetna Better Health is managed through CVS Health Specialty Pharmacy. The Specialty pharmacies fill prescriptions and ship drugs for complex medical conditions, including multiple sclerosis, rheumatoid

More information

Michigan Department of Health & Human Services Quantity Limitations

Michigan Department of Health & Human Services Quantity Limitations Abstral (fentanyl) sl tab all strength Acetaminophen Actonel Actonel 35mg Adderall XR 5mg, 10mg, 15mg Advair Diskus Advair HFA Aero Chambers and Spacers Aerobid Aerobid M Albuterol HFA 90mcg Akynzeo Aldara

More information

Pharmacy and Medical Guideline Updates

Pharmacy and Medical Guideline Updates STAT Bulletin PO Box 15013 Albany, New York 12212 August 2, 2010 Volume 8: Issue 19 To: All PCPs and Specialists Contracts Affected: All Lines of Business Pharmacy and ical Guideline Updates As a result

More information

THIRD QUARTER 2017 UPDATE CHANGES TO THE HIGHMARK DRUG FORMULARIES

THIRD QUARTER 2017 UPDATE CHANGES TO THE HIGHMARK DRUG FORMULARIES THIRD QUARTER 2017 UPDATE CHANGES TO THE HIGHMARK DRUG FORMULARIES Following is the Third Quarter 2017 update to the Highmark Drug Formularies and pharmaceutical management procedures. The formularies

More information

Prescription Drug Benefit Rider

Prescription Drug Benefit Rider Prescription Drug Benefit Rider Your Certificate of Coverage is amended as described in this document. This Rider becomes a part of your Certificate of Coverage and is subject to all provisions of your

More information

August 10, 2017 DURB Meeting Summary

August 10, 2017 DURB Meeting Summary Roll Call Present: Dr. Swee, Dr. Zanna (ex officio), Dr. Gooen, Dr. Marcus, Dr. Gochfeld, Dr. Moynihan, Dr. Moore, Ms. Olson, Dr. Lind (ex officio) Unable to attend: Mr. Schafer, Dr. Barberio Public Notice

More information

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice Quarterly pharmacy formulary change notice Summary of change: The Pharmacy and Therapeutics Committee (P&T) reviewed and approved the formulary changes listed in the table below on March 29, 2016. What

More information

North Dakota Medicaid Therapeutic Duplication Edits

North Dakota Medicaid Therapeutic Duplication Edits North Dakota Medicaid Therapeutic Duplication Edits This document is meant to serve as a guide to ND Medicaid s Therapeutic Duplication Edit which is reported as NCPDP Reject Code: 88 DUR REJECT ERROR.

More information

ALBUTEROL - SCORE. Products Affected. Details. Step Therapy Criteria Optima Tier Gold Formulary Date Effective: November 1, 2018.

ALBUTEROL - SCORE. Products Affected. Details. Step Therapy Criteria Optima Tier Gold Formulary Date Effective: November 1, 2018. ALBUTEROL - SCORE Ventolin Hfa Trial of ProAir Formulary ID 18354, Version 15 1 ANTIDEPRESSANTS - SCORE Aplenzin Desvenlafaxine Er TB24 100MG, 50MG Emsam Fetzima Fetzima Titration Pack Trial of two of

More information

Michigan Department of Health & Human Services Quantity Limitations

Michigan Department of Health & Human Services Quantity Limitations Quantity s Abstral (fentanyl) sl tab all strength acetaminophen Actonel Actonel 35mg Adderall XR 5mg, 10mg, 15mg Advair Diskus Advair HFA Aero Chambers and Spacers Aerobid Aerobid M albuterol HFA 90mcg

More information

STEP THERAPY ALGORITHMS PUP Select Formulary

STEP THERAPY ALGORITHMS PUP Select Formulary The Step Therapy drug will be dispensed if the drug has been dispensed within 120 days of current fill or if alternative (Step 1) drugs have been used first. If the member s prescription claim fails the

More information

ALBUTEROL - SCORE. Products Affected. Details. Step Therapy Criteria Health Choice Generations 1 Tier Gold Effective Date: 11/01/2018.

ALBUTEROL - SCORE. Products Affected. Details. Step Therapy Criteria Health Choice Generations 1 Tier Gold Effective Date: 11/01/2018. ALBUTEROL - SCORE Ventolin Hfa Trial of ProAir Formulary ID: 18349, Ver.15 Last Updated 10/23/2018 Effective Date: 11/1/2018 1 ANTIDEPRESSANTS - SCORE Aplenzin Desvenlafaxine Er TB24 100MG, 50MG Emsam

More information

UPMC for You Pharmacy and Therapeutics Committee Meeting July 27, 2010 meeting

UPMC for You Pharmacy and Therapeutics Committee Meeting July 27, 2010 meeting 1. Call to order: The meeting was called to order at 7:10 a.m. UPMC for You Pharmacy and Therapeutics Committee Meeting July 27, 2010 meeting 2. Review of the minutes: The minutes of the April 6, 2010

More information

1, 2014 PHARMACY BENEFIT

1, 2014 PHARMACY BENEFIT Effective 01/01/2007City of Plano Employee Benefit Design Summary Effective Date: January 1, 2014 PHARMACY BENEFIT CVS/CAREMARK TOLLFREE: 888-850-8245 ID CARD & NETWORK PHARMACIES: Identification Card

More information

Morphine Sulfate Hydromorphone Oxymorphone

Morphine Sulfate Hydromorphone Oxymorphone Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.02.33 Subject: Morphine Drug Class Page: 1 of 8 Last Review Date: June 19, 2015 Morphine Sulfate Hydromorphone

More information

DIFICID. Products Affected Step 2: DIFICID TABLET 200 MG ORAL. Details

DIFICID. Products Affected Step 2: DIFICID TABLET 200 MG ORAL. Details DIFICID DIFICID TABLET 200 MG ORAL Claim will pay automatically for Dificid if enrollee has a paid claim for at least a 1 days supply of vancomycin in the past. Otherwise, Dificid requires a step therapy

More information

These programs and quantity limitations may not apply. Check your certificate or other plan information for benefit details.

These programs and quantity limitations may not apply. Check your certificate or other plan information for benefit details. FlexRx Standard Utilization Management (PA, QL,) Updates January 1, 2018 How to use this drug list This drug list includes updates to Utilization Management (UM) programs. UM may include a prior authorization

More information

Granite Alliance Insurance Company (PDP) 2018 Step Therapy Criteria Last Updated: 10/23/18

Granite Alliance Insurance Company (PDP) 2018 Step Therapy Criteria Last Updated: 10/23/18 Granite Alliance Insurance Company (PDP) 2018 Step Therapy Criteria Last Updated: 10/23/18 Granite Alliance requires step therapy for certain drugs. This means prior to receiving a drug with a step therapy

More information

: Opioid Quantity Limits

: Opioid Quantity Limits March 7, 2017 2017-09: Opioid Quantity Limits The Louisiana Department of Health (LDH), in conjunction with the Louisiana Medicaid Drug Utilization Review (DUR) Board, has revised quantity limits for selected

More information

Transmucosal Immediate Release Fentanyl (TIRF) Prior Authorization, (Through Generic), and Quantity Limit Program Summary

Transmucosal Immediate Release Fentanyl (TIRF) Prior Authorization, (Through Generic), and Quantity Limit Program Summary Transmucosal Immediate Release Fentanyl (TIRF) Prior Authorization, (Through Generic), and Quantity Limit Program Summary FDA APPROVED INDICATIONS DOSAGE 1-5 Drug Indication Dosage Abstral (fentanyl sublingual

More information

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice Provider update Quarterly pharmacy formulary change notice Summary: The formulary changes listed in the table below were reviewed and approved at our first-quarter 2018, Pharmacy and Therapeutics Committee

More information

ALBUTEROL - SCORE{XE "ALBUTEROL - SCORE"}

ALBUTEROL - SCORE{XE ALBUTEROL - SCORE} Step Therapy ALBUTEROL - SCORE{XE "ALBUTEROL - SCORE"} Ventolin Hfa{XE "Ventolin Hfa"} Trial of ProAir Formulary ID# 00018097 Last Updated: 04/01/2018 1 ANTIDEPRESSANTS - SCORE{XE "ANTIDEPRESSANTS - SCORE"}

More information

Regulatory Status FDA-approved indication: Orencia is a selective T cell costimulation modulator indicated for: (1)

Regulatory Status FDA-approved indication: Orencia is a selective T cell costimulation modulator indicated for: (1) Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.70.18 Subject: Orencia Page: 1 of 6 Last Review Date: December 8, 2017 Orencia Description Orencia (abatacept)

More information

MEDICAL ASSISTANCE BULLETIN

MEDICAL ASSISTANCE BULLETIN ISSUE DATE February 18, 2015 SUBJECT EFFECTIVE DATE January 21, 2015 MEDICAL ASSISTANCE BULLETIN NUMBER *See below BY Drug List (PDL) Update January 21, 2015 Pharmacy Services Vincent D. Gordon, Deputy

More information

Pharmacy Services Request Types

Pharmacy Services Request Types FOR DRUG REQUESTS, ONLY-- * NOTE: Only those drugs administered by a healthcare provider and billed medically would be entered via CareAffiliate. * Oral drugs would not be administered by a healthcare

More information

NATL. II. Health Net Approved Indications and Usage Guidelines: Diagnosis of cancer AND. Member is on fentanyl transdermal patches AND

NATL. II. Health Net Approved Indications and Usage Guidelines: Diagnosis of cancer AND. Member is on fentanyl transdermal patches AND Coverage of drugs is first determined by the member s pharmacy or medical benefit. Please consult with or refer to the Evidence of Coverage document I. FDA Approved Indications: The management of breakthrough

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: Transmucosal Immediate Release Fentanyl Products Reference Number: CP.HNMC.211 Effective Date: 11.16.16 Last Review Date: 11.17 Line of Business: Medicaid Medi-Cal Revision Log See Important

More information

LIMITED DISTRIBUTION MEDICATIONS

LIMITED DISTRIBUTION MEDICATIONS ACTEMRA IV (USSC can dispense 162 mg PFS) ACTHAR HP ACTIMMUNE ADAGEN ADCETRIS CVS Specialty 1-800-237-2767 1-800-237-2767 ADEMPAS ADVATE ALDURAZYME ALECENSA ALIQOPA ALUNBRIG AMPYRA APOKYN ARALAST NP ARCALYST

More information

Limitations of use: Subsys may be dispensed only to patients enrolled in the TIRF REMS Access program (1).

Limitations of use: Subsys may be dispensed only to patients enrolled in the TIRF REMS Access program (1). Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.70.21 Subject: Subsys Page: 1 of 5 Last Review Date March 17, 2017 Subsys Description Subsys (fentanyl

More information

Texas Vendor Drug Program. Pharmacy Provider Procedure Manual. Vitamin and Mineral Products. Effective Date. November 2017

Texas Vendor Drug Program. Pharmacy Provider Procedure Manual. Vitamin and Mineral Products. Effective Date. November 2017 Texas Vendor Drug Program Pharmacy Provider Procedure Manual Vitamin and Mineral Products Effective Date November 2017 The Pharmacy Provider Procedure Manual (PPPM) is available online at txvendordrug.com/about/policy/manual.

More information

Michigan Department of Community Health Co-pay and Quantity Limitations

Michigan Department of Community Health Co-pay and Quantity Limitations Michigan Department of Community Health Co-pay and Quantity Limitations Benefit Plan Co-pay Information Group ID Coverage Co-pay INCARCE Incarcerated Medicaid No coverage No coverage patients SHPDUAL CSHCSCAID

More information

Formulary Changes. One mission: you TABLE A. FORMULARY CHANGES 7/1/2018: Commercial 3-Tier Formulary. Commercial 4-Tier Formulary

Formulary Changes. One mission: you TABLE A. FORMULARY CHANGES 7/1/2018: Commercial 3-Tier Formulary. Commercial 4-Tier Formulary One mission: you Changes July 1, 2018 Blue Cross of Idaho reviews its formularies (covered drug lists) periodically to allow members access to new drugs and to provide safe, cost effective options for

More information

ALBUTEROL - SCORE. Products Affected. Details. Step Therapy Criteria Farm Bureau Health Plans Date Effective: November 1, 2018.

ALBUTEROL - SCORE. Products Affected. Details. Step Therapy Criteria Farm Bureau Health Plans Date Effective: November 1, 2018. ALBUTEROL - SCORE Ventolin Hfa Trial of ProAir Formulary ID 18351, Version 15 1 ANTIDEPRESSANTS - SCORE Desvenlafaxine Er TB24 100MG, 50MG Emsam Fetzima Fetzima Titration Pack Trial of two of the following

More information

SELF-ADMINISTERED MEDICATIONS LIST

SELF-ADMINISTERED MEDICATIONS LIST SELF-ADMINISTERED MEDICATIONS LIST Table of Contents Page Last Updated: January 23, 2019 INSTRUCTIONS FOR USE... 1 APPLICABLE CODES... 1 Related Commercial Policy LIST HISTORY/REVISION INFORMATION... 5

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Lin DH, Jones CM, Compton WM, et al. Prescription drug coverage for treatment of low back pain among US Medicaid, Medicare Advantage, and commercial insurers. JAMA Netw Open.

More information

ALOGLIPTIN STEP. Details. Step Therapy Requirements Effective November 1, 2017

ALOGLIPTIN STEP. Details. Step Therapy Requirements Effective November 1, 2017 ALOGLIPTIN STEP alogliptin 12.5 mg tablet alogliptin 12.5 mg-metformin 1,000 mg tablet alogliptin 12.5 mg-metformin 500 mg tablet alogliptin 12.5 mg-pioglitazone 15 mg tablet alogliptin 12.5 mg-pioglitazone

More information

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Medical Policy An independent licensee of the Blue Cross Blue Shield Association Otezla (apremilast) Page 1 of 7 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Otezla (apremilast) Prime Therapeutics will review Prior Authorization requests Prior

More information

UnitedHealthcare Pharmacy Clinical Pharmacy Programs

UnitedHealthcare Pharmacy Clinical Pharmacy Programs Program Number 2017 P 3041-8 Program Step Therapy Medications UnitedHealthcare Pharmacy Clinical Pharmacy Programs *Orencia (abatacept) *This step criteria refers to the subcutaneous formulation of abatacept

More information

Regulatory Status FDA-approved indication: Orencia is a selective T cell costimulation modulator indicated for: (1)

Regulatory Status FDA-approved indication: Orencia is a selective T cell costimulation modulator indicated for: (1) Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.70.18 Subject: Orencia Page: 1 of 8 Last Review Date: March 16, 2018 Orencia Description Orencia (abatacept)

More information

Reason for change. Recently approved. Recently approved. Recently approved. Recently approved. Recently updated. Recently approved.

Reason for change. Recently approved. Recently approved. Recently approved. Recently approved. Recently updated. Recently approved. 2017 Formulary Change Notice Please note these changes to your 2017 List of Covered Drugs Drug name (medication) Rubraca Aprepitant Onivyde Oseltamivir Restasis Xiidra Daptomycin Selzentry Linzess Butalb/APAP/caff

More information

Alabama Medicaid Preferred Drug and Prior Authorization Program

Alabama Medicaid Preferred Drug and Prior Authorization Program Alabama Medicaid Preferred Drug and Prior Authorization Program Prior Authorization (PA) Criteria Instructions This document contains detailed instructions on completing the Medicaid Prior Authorization

More information

Pulmonary Hypertension Weight Loss Skin Conditions. Skin Conditions Multiple Sclerosis Endocrine Disorder. Endocrine Disorder.

Pulmonary Hypertension Weight Loss Skin Conditions. Skin Conditions Multiple Sclerosis Endocrine Disorder. Endocrine Disorder. Prior Authorization PricewaterhouseCoopers The following medications may require prior authorization prior to dispensing at a participating retail pharmacy or through the Express Scripts Pharmacy home

More information

2009 Workers' Compensation Drug Trend Report. An analysis of trend and a forecast for the future

2009 Workers' Compensation Drug Trend Report. An analysis of trend and a forecast for the future 2009 Workers' Compensation Drug Trend Report An analysis of trend and a forecast for the future Published April 2010 LEAD AUTHORS Emily Cox, PhD, RPh Yakov Svirnovskiy Jennifer Kaburick, RN Ruth Martinez,

More information

Nucynta IR/ Nucynta ER (tapentadol immediate-release and extendedrelease)

Nucynta IR/ Nucynta ER (tapentadol immediate-release and extendedrelease) Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 Subject: Nucynta Page: 1 of 7 Last Review Date: March 18, 2016 Nucynta Description Nucynta IR/ Nucynta

More information

Aetna Better Health Illinois Premier Plan. November 2015 Formulary Updates. October 2015 Formulary Updates

Aetna Better Health Illinois Premier Plan. November 2015 Formulary Updates. October 2015 Formulary Updates Aetna Better Health Illinois Premier Plan November 2015 Formulary Updates desogestrel & ethinyl estradiol tab 0.15 mg-30 mcg RIVASTIGMINE DIS 13.3/24; QL (30 patches/30 days) RIVASTIGMINE DIS 4.6MG/24;

More information

Step Therapy Criteria

Step Therapy Criteria Step Therapy Group ADCIRCA 1772-D ADCIRCA Coverage will be provided if the member has filled a prescription for sildenafil (at least a 30 day supply within the past 365 Step Therapy Group ANTIPSYCHOTICS

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: Transmucosal Immediate Release Fentanyl Products Reference Number: CP.CPA.211 Effective Date: 11.16.16 Last Review Date: 11.17 Line of Business: Commercial Revision Log See Important Reminder

More information

Capital BlueCross Open/Closed Formulary Update (1 st Quarter 2017)

Capital BlueCross Open/Closed Formulary Update (1 st Quarter 2017) Capital BlueCross Open/Closed Formulary Update (1 st Quarter 2017) The Capital BlueCross formulary is a reference list of prescription drugs that contains a wide range of generic and brand drugs that have

More information

Magellan Rx. A smarter approach to pharmacy benefits management

Magellan Rx. A smarter approach to pharmacy benefits management Magellan Rx A smarter approach to pharmacy benefits management Presented by: Cheri Caruso, VP of Sales, Magellan Rx Management Bryce Canfield, VP, Client Development, GoodRx A unique vision of care We

More information

MedStar Medicare Choice Pharmacy Services

MedStar Medicare Choice Pharmacy Services Pharmacy Services 1 MedStar Medicare Choice Pharmacy Services Table of Contents At a Glance..page 2 Pharmacy Policies..page 4 Medicare Choice Pharmacy Programs..page 6 Where to Obtain Prescriptions..page

More information

Medication trends shaping workers compensation. A 2018 mid-year review of the prevailing industry influences impacting pharmacy outcomes

Medication trends shaping workers compensation. A 2018 mid-year review of the prevailing industry influences impacting pharmacy outcomes Medication trends shaping workers compensation A 2018 mid-year review of the prevailing industry influences impacting pharmacy outcomes OPTUM WORKERS COMPENSATION DATA SET Analysis of our data, the industry

More information

Biologic Immunomodulators Prior Authorization with Quantity Limit Program Summary

Biologic Immunomodulators Prior Authorization with Quantity Limit Program Summary Biologic Immunomodulators Prior Authorization with Quantity Limit Program Summary Biologic Immunomodulators Prior Authorization with Quantity Limit (with a preferred option) OBJECTIVE The intent of the

More information

Movantik (naloxegol), Relistor (methylnaltrexone bromide)

Movantik (naloxegol), Relistor (methylnaltrexone bromide) Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.50.06 Subject: Opioid Antagonist Drug Class Page: 1 of 5 Last Review Date: December 2, 2016 Opioid Antagonist

More information

Therapeutic Class Indications Effective

Therapeutic Class Indications Effective Mortar & Pestle A Publication of Walgreens Health Initiatives July 30, 2009 A publication created especially for our clients and associates, delivering up-to-date information about brand-name and generic,

More information

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice Quarterly pharmacy formulary change notice Provider update Summary: Effective August 1, 2018, the preferred formulary changes detailed in the table below will apply to District of Columbia Healthy Families

More information

Regulatory Status FDA approved indication: Kineret is an interleukin-1 receptor antagonist indicated for: (1)

Regulatory Status FDA approved indication: Kineret is an interleukin-1 receptor antagonist indicated for: (1) Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.70.50 Subject: Kineret Page: 1 of 5 Last Review Date: March 17, 2017 Kineret Description Kineret (anakinra)

More information

STEP THERAPY CRITERIA

STEP THERAPY CRITERIA STEP THERAPY This is a complete list of drugs that have written coverage determination policies. Drugs on this list do not indicate that this particular drug will be covered under your medical or prescription

More information

THIRD QUARTER 2017 UPDATE CHANGES TO THE HIGHMARK DRUG FORMULARIES

THIRD QUARTER 2017 UPDATE CHANGES TO THE HIGHMARK DRUG FORMULARIES THIRD QUARTER 2017 UPDATE CHANGES TO THE HIGHMARK DRUG FORMULARIES Following is the Third Quarter 2017 update to the Highmark Drug Formularies and pharmaceutical management procedures. The formularies

More information

PAIN. TREATMENT TABLES Analgesics. NON-OPIOID ANALGESICS Generic Name Trade Names (Examples) Duration Initial Dose

PAIN. TREATMENT TABLES Analgesics. NON-OPIOID ANALGESICS Generic Name Trade Names (Examples) Duration Initial Dose NON-OPIOID SHORT-ACTING LONG-ACTING **** O PAIN TREATMENT TABLES Analgesics NON-OPIOID ANALGESICS Generic Name Trade Names (Examples) Duration Initial Dose Tramadol 50 mg Ultram Every 4 hours 1-2 tabs,

More information

Movantik (naloxegol), Relistor (methylnaltrexone bromide), Symproic (naldemedine)

Movantik (naloxegol), Relistor (methylnaltrexone bromide), Symproic (naldemedine) Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.50.06 Subject: Opioid Antagonist Drug Class Page: 1 of 5 Last Review Date: June 22, 2017 Opioid Antagonist

More information

Step Therapy Criteria

Step Therapy Criteria ADCIRCA 1772-D ADCIRCA Coverage will be provided if the member has filled a prescription for sildenafil (at least a 30 day supply within the past 365 AMYLIN ANALOG 676-D SYMLINPEN 120, SYMLINPEN 60 rapid-acting

More information

Quarterly pharmacy formulary change

Quarterly pharmacy formulary change Medi-Cal Managed Care L. A. Care Major Risk Medical Insurance Program Provider Bulletin The formulary changes listed in the table below were reviewed and approved at our first-quarter 2018 Pharmacy and

More information